{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:14:55Z","timestamp":1792440895611,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:p>Chronic kidney dysfunction is associated with increased mortality in multiple cancer types. Preliminary evidence suggests the same to be true for B-large cell lymphomas (B-LCL). To analyze the relationship of glomerular filtration rate (GFR) and outcome of B-LCL in detail we collected data on outcomes of 285 consecutive patients with newly diagnosed B-LCL treated at our institution with standard rituximab-containing regimens who did not have preexisting kidney disease or urinary tract obstruction at presentation. Median age was 59, range 18 to 87, 145 were male and 140 females. Forty-four had GFR\u2005&lt;\u200560\u2009mL\/min, 123 had 60 to 90\u2009mL\/min, and 118\u2005&gt;\u200590\u2009mL\/min. Median follow-up of surviving patients was 49 months and estimated 3-year survival 76%. In univariate analysis age (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), GFR (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.014), stage (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), performance status (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.044), chemotherapy regimen (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.01), and international prognostic index (IPI) (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001) were statistically significant prognostic factors. In multivariate analysis, age and GFR remained the only independent prognostic factors. Subtracting 1 from the IPI score of patients who had GFR\u2005&gt;\u200590\u2009mL\/min and IPI\u2005&gt;\u20051 resulted in a prognostic index that divides patients into 3 prognostic groups (low risk\u2005=\u20050\u20131, intermediate risk\u2005=\u20052\u20133 and high risk\u2005=\u20054\u20135) with an acceptable patient distribution frequency (38%, 39%, and 23%, respectively) and improved statistical significance and separation in comparison to IPI (5-year survival rates of 92%, 74%, and 42%, respectively). GFR is an important independent prognostic factor for B-LCL that should be taken into account in clinical decision making and data analysis and probably be incorporated in prognostic indices.<\/jats:p>","DOI":"10.1097\/md.0000000000033675","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:06:05Z","timestamp":1684451165000},"page":"e33675","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6264-6809","authenticated-orcid":false,"given":"Vedran","family":"Premu\u017ei\u0107","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University Hospital Centre Zagreb"},{"name":"Medical School, University of Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ba\u0161i\u0107-Kinda","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Radman","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Dujmovi\u0107","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Ili\u0107","sequence":"additional","affiliation":[{"name":"Medical School, University of Zagreb"},{"name":"Department of Pathology, University Hospital Centre Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neno","family":"\u017divkovi\u0107","sequence":"additional","affiliation":[{"name":"Medical School, University of Zagreb"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucija","family":"Maleta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kralik","sequence":"additional","affiliation":[{"name":"Department of Radiology, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Dobreni\u0107","sequence":"additional","affiliation":[{"name":"Medical School, University of Zagreb"},{"name":"Department of Nuclear Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Galuni\u0107-Bili\u0107","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavle","family":"Ron\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijo","family":"Vodanovi\u0107","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Aurer","sequence":"additional","affiliation":[{"name":"Medical School, University of Zagreb"},{"name":"Division of Hematology, Department of Internal Medicine, UHC Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.09011010","article-title":"Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.","volume":"6","author":"Weng","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1014489911153","article-title":"Increased incidence of neoplasia in chronic renal failure (20-year experience).","volume":"33","author":"Cengiz","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/annonc\/mdt431","article-title":"Cancer and the kidney: individualizing dosage according to renal function.","volume":"24","author":"Launay-Vacher","year":"2013","journal-title":"Ann Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.","volume":"110","author":"Launay-Vacher","year":"2007","journal-title":"Cancer"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11606-010-1511-x","article-title":"Chronic kidney disease and the risk of end-stage renal disease versus death.","volume":"26","author":"Dalrymple","year":"2011","journal-title":"J Gen Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2013.07.008","article-title":"Reduced estimated GFR and cancer mortality.","volume":"63","author":"Iff","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1681\/ASN.2005040384","article-title":"Kidney function as a predictor of noncardiovascular mortality.","volume":"16","author":"Fried","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000356084","article-title":"Loss of renal function causes premature aging of the immune system.","volume":"36","author":"Betjes","year":"2013","journal-title":"Blood Purif"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease.","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality.","volume":"33","author":"Na","year":"2011","journal-title":"Am J Nephrol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e3728","DOI":"10.1097\/MD.0000000000003728","article-title":"Renal function and all-cause mortality risk among cancer patients.","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network.","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5045\/br.2013.48.2.115","article-title":"Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry.","volume":"48","author":"Yi","year":"2013","journal-title":"Blood Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5045\/br.2016.51.2.113","article-title":"Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma.","volume":"51","author":"Hong","year":"2016","journal-title":"Blood Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e9615","DOI":"10.1097\/MD.0000000000009615","article-title":"Prevalence and mortality of chronic kidney disease in lymphoma patients: a large retrospective cohort study.","volume":"97","author":"Ubukata","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00277-020-04353-3","article-title":"R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.","volume":"100","author":"Ba\u0161i\u0107-Kinda","year":"2021","journal-title":"Ann Hematol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2215\/CJN.03110410","article-title":"The CKD-EPI equation for estimating GFR from serum creatinine: real improvement or more of the same?","volume":"5","author":"Rule","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1681\/ASN.2013060604","article-title":"CKD and the risk of incident cancer.","volume":"25","author":"Lowrance","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","article-title":"Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.","volume":"161","author":"Witko-Sarsat","year":"1998","journal-title":"J Immunol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1681\/ASN.V1271549","article-title":"The microinflammatory state in uremia: causes and potential consequences.","volume":"12","author":"Kaysen","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2009.01.026","article-title":"Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey.","volume":"122","author":"Wilhelm-Leen","year":"2009","journal-title":"Am J Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.jrn.2011.10.020","article-title":"Effect of uremia on structure and function of immune system.","volume":"22","author":"Vaziri","year":"2012","journal-title":"J Ren Nutr"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin\u00b4s disease: results of a BNLI randomised trial.","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3906\/sag-1809-36","article-title":"Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed\/refractory lymphoma.","volume":"49","author":"Okay","year":"2019","journal-title":"Turk J Med Sci"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1301077","article-title":"Autologous transplantation as consolidation for aggressive non-Hodgkin\u2019s lymphoma.","volume":"369","author":"Stiff","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:03:44Z","timestamp":1746324224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":28,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033675","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}